JP2023516632A5 - - Google Patents

Info

Publication number
JP2023516632A5
JP2023516632A5 JP2022552125A JP2022552125A JP2023516632A5 JP 2023516632 A5 JP2023516632 A5 JP 2023516632A5 JP 2022552125 A JP2022552125 A JP 2022552125A JP 2022552125 A JP2022552125 A JP 2022552125A JP 2023516632 A5 JP2023516632 A5 JP 2023516632A5
Authority
JP
Japan
Prior art keywords
cells
concentration
cell
induction medium
bulk
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022552125A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023516632A (ja
JP7778708B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/019917 external-priority patent/WO2021174004A1/en
Publication of JP2023516632A publication Critical patent/JP2023516632A/ja
Publication of JP2023516632A5 publication Critical patent/JP2023516632A5/ja
Application granted granted Critical
Publication of JP7778708B2 publication Critical patent/JP7778708B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022552125A 2020-02-28 2021-02-26 多能性幹細胞からナチュラルキラー細胞を産生するための方法 Active JP7778708B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062983511P 2020-02-28 2020-02-28
US62/983,511 2020-02-28
PCT/US2021/019917 WO2021174004A1 (en) 2020-02-28 2021-02-26 Method for producing natural killer cells from pluripotent stem cells

Publications (3)

Publication Number Publication Date
JP2023516632A JP2023516632A (ja) 2023-04-20
JP2023516632A5 true JP2023516632A5 (enExample) 2024-03-05
JP7778708B2 JP7778708B2 (ja) 2025-12-02

Family

ID=75108897

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022552125A Active JP7778708B2 (ja) 2020-02-28 2021-02-26 多能性幹細胞からナチュラルキラー細胞を産生するための方法

Country Status (14)

Country Link
US (1) US12351824B2 (enExample)
EP (1) EP4110904A1 (enExample)
JP (1) JP7778708B2 (enExample)
KR (1) KR20220148174A (enExample)
CN (1) CN115427555A (enExample)
AR (1) AR121455A1 (enExample)
AU (1) AU2021225952A1 (enExample)
BR (1) BR112022017216A2 (enExample)
CA (1) CA3169617A1 (enExample)
CO (1) CO2022011682A2 (enExample)
IL (1) IL295964A (enExample)
MX (1) MX2022010521A (enExample)
TW (1) TWI886220B (enExample)
WO (1) WO2021174004A1 (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11459372B2 (en) 2020-11-30 2022-10-04 Crispr Therapeutics Ag Gene-edited natural killer cells
US11473060B2 (en) 2020-12-30 2022-10-18 Crispr Therapeutics Ag Compositions and methods for differentiating stem cells into NK cells
CN113801846B (zh) * 2021-09-22 2024-06-04 南京艾尔普再生医学科技有限公司 一种从人诱导多能干细胞分化为自然杀伤细胞的方法
CN114517176B (zh) * 2022-01-27 2022-12-02 广东普罗凯融生物医药科技有限公司 一种将ips细胞诱导成nk细胞的试剂盒及其应用方法
CN114350608B (zh) * 2022-01-27 2024-05-28 昭泰英基生物医药（香港）有限公司 一种诱导t细胞重编程为类nk细胞的组合物及其应用
JPWO2024004960A1 (enExample) 2022-06-27 2024-01-04
WO2024101862A1 (ko) * 2022-11-07 2024-05-16 마루테라퓨틱스 주식회사 Nk 세포의 분화 효율 및 기능성 증가를 위한 배양 방법
WO2024107010A1 (ko) * 2022-11-17 2024-05-23 주식회사 씨티셀즈 미분화 줄기세포로부터 자연 살해 세포로의 분화 방법 및 이의 용도
CN115537397B (zh) * 2022-12-02 2023-03-24 广东先康达细胞库有限公司 Nk细胞诱导培养基及其培养方法
CN118667760A (zh) * 2023-03-17 2024-09-20 深圳市三启生物技术有限公司 诱导多能干细胞分化为cd34+造血干/祖细胞的培养基组合
WO2024224359A1 (en) * 2023-04-27 2024-10-31 Takeda Pharmaceutical Company Limited Method for expanding cd56+/cd3- cells
CN116410336B (zh) * 2023-06-02 2023-09-22 云南赛元生物技术有限公司 一种嵌合抗原受体的编码核苷酸、car-nk细胞及其构建方法和应用
CN117050941B (zh) * 2023-10-11 2024-01-26 苏州艾凯利元生物科技有限公司 一种制备自然杀伤细胞的方法
CN117050940B (zh) * 2023-10-11 2024-01-26 苏州艾凯利元生物科技有限公司 一种制备自然杀伤细胞的方法

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4797368A (en) 1985-03-15 1989-01-10 The United States Of America As Represented By The Department Of Health And Human Services Adeno-associated virus as eukaryotic expression vector
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US5139941A (en) 1985-10-31 1992-08-18 University Of Florida Research Foundation, Inc. AAV transduction vectors
US6013516A (en) 1995-10-06 2000-01-11 The Salk Institute For Biological Studies Vector and method of use for nucleic acid delivery to non-dividing cells
US5928906A (en) 1996-05-09 1999-07-27 Sequenom, Inc. Process for direct sequencing during template amplification
US5994136A (en) 1997-12-12 1999-11-30 Cell Genesys, Inc. Method and means for producing high titer, safe, recombinant lentivirus vectors
US9453219B2 (en) 2003-05-15 2016-09-27 Mello Biotech Taiwan Co., Ltd. Cosmetic designs and products using intronic RNA
CN101864392B (zh) 2005-12-13 2016-03-23 国立大学法人京都大学 核重新编程因子
EP3399025B1 (en) 2007-03-23 2025-05-07 Wisconsin Alumni Research Foundation Somatic cell reprogramming
JP2008307007A (ja) 2007-06-15 2008-12-25 Bayer Schering Pharma Ag 出生後のヒト組織由来未分化幹細胞から誘導したヒト多能性幹細胞
EP2198011B1 (en) 2007-08-31 2016-06-08 Whitehead Institute for Biomedical Research Wnt pathway stimulation in reprogramming somatic cells
AU2008297024B2 (en) 2007-10-31 2014-08-28 Kyoto University Nuclear reprogramming method
JP5558097B2 (ja) 2007-12-10 2014-07-23 国立大学法人京都大学 効率的な核初期化方法
CA2709566A1 (en) 2007-12-17 2009-06-25 Gliamed, Inc. Stem-like cells and method for reprogramming adult mammalian somatic cells
WO2009091659A2 (en) 2008-01-16 2009-07-23 Shi-Lung Lin Generation of tumor-free embryonic stem-like pluripotent cells using inducible recombinant rna agents
EP2250252A2 (en) 2008-02-11 2010-11-17 Cambridge Enterprise Limited Improved reprogramming of mammalian cells, and the cells obtained
EP2090649A1 (en) 2008-02-13 2009-08-19 Fondazione Telethon Method for reprogramming differentiated cells
US20110014164A1 (en) 2008-02-15 2011-01-20 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
JP5951254B2 (ja) 2008-03-17 2016-07-13 ザ スクリプス リサーチ インスティテュート 人工多能性幹細胞を作製するための化学的手法と遺伝的手法の組み合わせ法
WO2009114949A1 (en) 2008-03-20 2009-09-24 UNIVERSITé LAVAL Methods for deprogramming somatic cells and uses thereof
EP2276838A4 (en) 2008-04-07 2012-02-01 Nupotential Inc RE-PROGRAMMING A CELL BY INDUCING A PLURIPOTENTIC GENE THROUGH RNA INTERFERENCE
KR101606943B1 (ko) 2008-06-27 2016-03-28 고쿠리츠 다이가쿠 호진 교토 다이가쿠 유도된 다능성 줄기 세포의 효율적인 확립 방법
US9453204B2 (en) 2008-07-14 2016-09-27 Oklahoma Medical Research Foundation Production of pluripotent cells through inhibition of bright/ARID3a function
WO2010147612A1 (en) 2009-06-18 2010-12-23 Lixte Biotechnology, Inc. Methods of modulating cell regulation by inhibiting p53
WO2010033920A2 (en) 2008-09-19 2010-03-25 Whitehead Institute For Biomedical Research Compositions and methods for enhancing cell reprogramming
WO2010033906A2 (en) 2008-09-19 2010-03-25 President And Fellows Of Harvard College Efficient induction of pluripotent stem cells using small molecule compounds
WO2010042800A1 (en) 2008-10-10 2010-04-15 Nevada Cancer Institute Methods of reprogramming somatic cells and methods of use for such cells
WO2010050626A1 (en) 2008-10-30 2010-05-06 Kyoto University Method for producing induced pluripotent stem cells
WO2010056831A2 (en) 2008-11-12 2010-05-20 Nupotential, Inc. Reprogramming a cell by inducing a pluripotent gene through use of an hdac modulator
EP2376626A4 (en) 2008-12-13 2012-10-17 Dna Microarray MICRO-ENVIRONMENTAL NICHE ASSAY FOR SCREENING OF INDUCED PLURIPOTENT STEM CELLS (CIPS)
CN102388136B (zh) 2009-02-27 2014-10-01 国立大学法人京都大学 新颖的核重编程序物质
US20120122212A1 (en) 2009-03-06 2012-05-17 Marica Grskovic Tgf-beta pathway inhibitors for enhancement of cellular reprogramming of human cells
WO2010111422A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Induced pluripotent stem cell generation using two factors and p53 inactivation
WO2010111409A2 (en) 2009-03-25 2010-09-30 The Salk Institute For Biological Studies Pluripotent stem cells
US8852940B2 (en) 2009-04-01 2014-10-07 The Regents Of The University Of California Embryonic stem cell specific microRNAs promote induced pluripotency
WO2010124290A2 (en) 2009-04-24 2010-10-28 Whitehead Institute For Biomedical Research Compositions and methods for deriving or culturing pluripotent cells
WO2010147395A2 (en) 2009-06-16 2010-12-23 Korea Research Institute Of Bioscience And Biotechnology Medium composition comprising neuropeptide y for the generation, maintenance, prologned undifferentiated growth of pluripotent stem cells and method of culturing pluripotent stem cell using the same
US20130011376A1 (en) 2009-12-29 2013-01-10 Gamida Cell Ltd. Methods for Enhancing Natural Killer Cell Proliferation and Activity
TWI654206B (zh) 2013-03-16 2019-03-21 諾華公司 使用人類化抗－ｃｄ１９嵌合抗原受體治療癌症
WO2016123100A1 (en) 2015-01-26 2016-08-04 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
EP3313420B1 (en) * 2015-06-25 2024-03-13 The Children's Medical Center Corporation Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance
ES2862676T3 (es) * 2015-10-20 2021-10-07 Fujifilm Cellular Dynamics Inc Producción de células precursoras hematopoyéticas multilinaje mediante programación genética
WO2017078807A1 (en) 2015-11-04 2017-05-11 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
CN109415699B (zh) * 2016-06-23 2024-08-27 国立大学法人京都大学 Cd4cd8双阳性t细胞的制备方法
AU2018254442B2 (en) 2017-04-18 2024-03-28 FUJIFILM Cellular Dynamics, Inc. Antigen-specific immune effector cells

Similar Documents

Publication Publication Date Title
Iriguchi et al. A clinically applicable and scalable method to regenerate T-cells from iPSCs for off-the-shelf T-cell immunotherapy
CN111235105B (zh) 一种从人多能干细胞分化为自然杀伤细胞的方法及应用
Zandstra et al. Expansion of hematopoietic progenitor cell populations in stirred suspension bioreactors of normal human bone marrow cells
Dege et al. Potently cytotoxic natural killer cells initially emerge from erythro-myeloid progenitors during mammalian development
Lyadova et al. Macrophages derived from human induced pluripotent stem cells: the diversity of protocols, future prospects, and outstanding questions
Petzer et al. Differential cytokine effects on primitive (CD34+ CD38-) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin.
Euchner et al. Natural killer cells generated from human induced pluripotent stem cells mature to CD56brightCD16+ NKp80+/-in-vitro and express KIR2DL2/DL3 and KIR3DL1
Mayani et al. Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells
Yamaguchi et al. Serum-free coculture system for ex vivo expansion of human cord blood primitive progenitors and SCID mouse-reconstituting cells using human bone marrow primary stromal cells
Spanholtz et al. Clinical-grade generation of active NK cells from cord blood hematopoietic progenitor cells for immunotherapy using a closed-system culture process
Ehring et al. Expansion of HPCs from cord blood in a novel 3D matrix
EP2669368A1 (en) Isolation and purification of hematopoietic stem cells from post-liposuction lipoaspirates
JP2012509666A5 (enExample)
CN115491354B (zh) 一种nk细胞分化的方法
Kanai et al. Stromal cell-dependent ex vivo expansion of human cord blood progenitors and augmentation of transplantable stem cell activity
JP2002532087A (ja) 初期のｃｄ３４＋ｃｄ３８−骨髄幹細胞の増大のためのヒト脳内皮細胞及び増殖培地並びに方法
Flippe et al. Rapid and reproducible differentiation of hematopoietic and T cell progenitors from pluripotent stem cells
CN117050941B (zh) 一种制备自然杀伤细胞的方法
KR20240037179A (ko) 만능 줄기 세포-유래 조혈 계통
CN117683713A (zh) 利用人多潜能干细胞体外制备t淋巴细胞和nk细胞
Alcorn et al. Ex vivo expansion of haemopoietic progenitor cells
CN114402065A (zh) 低密度细胞培养
US20240218328A1 (en) Compositions and methods for differentiating and expanding b lineage cells
JP2024523332A5 (enExample)
Kawai et al. Feeder-free generation of CD4 single-positive helper T cells from human iPSCs via stage-specific modulation of Notch and TCR Signaling